Viking Therapeutics Inc (VKTX)

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	7.41% 29.29	27.27	23.74	20.54	20.28
Operating Income/Loss	7.41% -29.29	-27.27	-23.74	-20.54	-20.28
Income/Loss From Continuing Operations Before Tax	9.19% -24.60	-22.53	-19.23	-19.53	-19.56
Income/Loss From Continuing Operations After Tax	9.19% -24.61	-22.53	-19.23	-19.53	-19.56
Net Income/Loss	9.19% -24.61	-22.53	-19.23	-19.53	-19.56
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.13% 1.866	99.85	99.01	78.35	-0.083
Diluted Average Shares	98.13% 1.866	99.85	99.01	78.35	-0.083
Basic Earnings Per Share	8.70% -0.25	-0.23	-0.19	-0.25	-0.26
Diluted Earnings Per Share	8.70% -0.25	-0.23	-0.19	-0.25	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-